Preureteric vena cava
Preureteric vena cava | |
---|---|
Synonyms | Circumcaval ureter, Retrocaval ureter |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Flank pain, hematuria, urinary tract infection |
Complications | Hydronephrosis, renal failure |
Onset | Congenital |
Duration | Lifelong |
Types | N/A |
Causes | Congenital anomaly |
Risks | None specifically known |
Diagnosis | Intravenous pyelogram, CT scan, MRI |
Differential diagnosis | Ureteral stricture, ureteral stone |
Prevention | N/A |
Treatment | Surgical intervention |
Medication | Analgesics, antibiotics for infections |
Prognosis | Good with treatment |
Frequency | Rare |
Deaths | Rarely, if untreated |
Preureteric vena cava, also known as circumaortic renal collar, is a rare anatomical variation in the venous system surrounding the ureter and the aorta. This condition involves the presence of a venous ring around the aorta, which can potentially lead to ureteral obstruction and subsequent hydronephrosis. Understanding the anatomy, clinical significance, and implications of a preureteric vena cava is crucial for accurate diagnosis and management of related urological conditions.
Anatomy and Physiology
The vena cava is a major vein that carries deoxygenated blood from the body back to the heart. There are two vena cavae in the human body: the superior vena cava and the inferior vena cava. The preureteric vena cava specifically refers to an anomaly involving the inferior vena cava (IVC) where the vein, or a part of it, encircles the ureter anteriorly before it enters the renal hilum. This anatomical variation can lead to compression of the ureter, affecting the normal flow of urine from the kidney to the bladder.
Etiology
The exact cause of a preureteric vena cava is not well understood, but it is believed to result from variations in the embryological development of the inferior vena cava. During fetal development, the IVC is formed from the merging of three pairs of veins: the posterior cardinal veins, the subcardinal veins, and the supracardinal veins. Anomalies in the regression and persistence of these venous systems can lead to the formation of a preureteric vena cava.
Clinical Significance
A preureteric vena cava can be asymptomatic but has the potential to cause significant clinical issues, including hydronephrosis due to ureteral obstruction. Symptoms of hydronephrosis may include flank pain, urinary tract infections, and decreased kidney function. The diagnosis of a preureteric vena cava is often incidental, discovered during imaging studies for unrelated conditions. However, in patients presenting with unexplained hydronephrosis, especially when it is associated with a history of urinary tract infections or renal dysfunction, a preureteric vena cava should be considered.
Diagnosis
Diagnosis of a preureteric vena cava typically involves imaging studies. Ultrasound can be used as a first-line imaging modality, but it may not always provide definitive evidence of the condition. Computed tomography (CT) and magnetic resonance imaging (MRI) are more effective in visualizing the vascular anatomy and can confirm the presence of a preureteric vena cava. These imaging techniques can also help in planning surgical interventions if necessary.
Management
The management of a preureteric vena cava depends on the severity of symptoms and the degree of ureteral obstruction. In asymptomatic cases, no treatment may be necessary, and patients can be managed with observation. For symptomatic cases, especially those with significant hydronephrosis, surgical intervention may be required to relieve the obstruction. Surgical options include ureterolysis with relocation of the ureter or vascular reconstruction of the inferior vena cava.
Conclusion
Preureteric vena cava is a rare vascular anomaly with potential clinical implications, including ureteral obstruction and hydronephrosis. Awareness of this condition is important for healthcare professionals, particularly those in urology and radiology, to ensure accurate diagnosis and appropriate management of affected individuals.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD